Absci is harnessing AI to design drug candidates for previously undruggable targets, unlocking new biology. Partnering with industry leaders like AstraZeneca, Absci blends its AI platform with pharma expertise to accelerate groundbreaking drugs into clinical development. Founder and CEO Sean McClain and Chief Innovation Officer Andreas Busch join For Your Innovation to detail the company's mission and goals. |
In a memo obtained by the NY Post, Trump...
FOX Business’ Jeff Flock reports on the ...
Investor's Business Daily Executive Edit...
Rep. Mike Lawler, R-N.Y., on the upcomin...
There is no simplistic split of sentimen...
The Heritage Foundation's EJ Antoni expl...
Americans for Tax Reform president Grove...
Michelle Caruso Cabrera, CNBC Contributo...
Dan Leonard, senior meteorologist with T...
Oliver Chen, TD Cowen, joins 'Fast Money...
The 'Fast Money' traders look back at th...
Big Tech has dominated investor portfoli...
Ready to unlock the power of digital inv...
Is quantum computing the next big thing?...
This robot’s design was inspired by four...
Record travel this holiday season means ...
ShotSpotter microphones are controversia...
This robot’s design was inspired by four...
Record travel this holiday season means ...
Ready to unlock the power of digital inv...
ShotSpotter microphones are controversia...
Is quantum computing the next big thing?...